257873
Descripción
Fichas por Mark George, actualizado hace más de 1 año
|
Creado por Mark George
hace más de 10 años
|
|
| Pregunta | Respuesta |
| BPH Patho Static Component | Proliferation of Glandular Epithelium (alterations of testosterone, estrogen, DHT) |
| BPH Patho Dynamic component | Increase in prostatic smooth muscle tone linked to altered activity of PICs (possibly contributes to increased prostate contractility) |
| BPH Pharmacology Finasteride | 5Alpha Reductase inhibitor Blocks conversion of testosterone into DHT Altered libido / Impotence |
| BPH Pharmacology Tamsulosin | Alpha1a adrenoceptor antagonist blocks prostatic smooth muscle receptors :- decreases Ca++ availability (decreased prostate contractility) Postural hypotension / GIT |
| BPH diagnostics DRE (digital rectal exam) | Physical exam determines the state and size of the external surface of the prostate gland |
| BPH Diagnostics PSA | Blood test that measures the level of specific antigen produced by both benign and malignant prostate tissue |
| BPH Clinical Manifestations (Obstructive) | proLONGed voiding. WEAK urinary stream. INCOMPLETE emptying. abdominal STRAINing. posturination DRIBBLE. |
| BPH Clinical manifestations (Irritative) | nocturia bladder PAIN URGENT urination incontinence |
| BPH Clinical manifestations (Ureter obstruction) | Bladder/kidney INFECTION acute urinary RETENTION RENAL INSUFFICIENcy HAEMATURIA |
¿Quieres crear tus propias Fichas gratiscon GoConqr? Más información.